Onesource Specialty Pharma Limited
NSE: ONESOURCE | Information Technology
Market Fundamentals
Stock Intelligence & News
Onesource Specialty Pharma Limited
In furtherance to the clarification sought by the exchange with regard to the OCR readable format of the financial results, Onesource Specialty Pharma Limited has submitted the OCR Readable financial results for the quarter and year ended March 31, 2026 |SUBJECT: Updates
Read Full Analysis →Onesource Specialty Pharma Limited
In furtherance to the intimation made on May 13, 2026, w.r.t the resignation of the SMP, Onesource Specialty Pharma Limited has informed the Exchange regarding resignation document of SMP. |SUBJECT: Updates
Read Full Analysis →Five Stocks To Buy: Aurobindo Pharma, Tata Communications, Graphite India And More | May 18, 2026
Top picks include pharma majors Aurobindo Pharma and OneSource Specialty Pharma, agrochemical player Sumitomo Chemical India, telecom giant Tata Communications, and industrial manufacturing firm Graphite India.
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Onesource Specialty Pharma Limited
ONESOURCE SPECIALTY PHARMA LIMITED has informed the Exchange about Change in Directors/KMP/SMP/Auditor/RTA |SUBJECT: Change in Directors/KMP/SMP/Auditor/RTA
Read Full Analysis →Onesource Specialty Pharma Limited
ONESOURCE SPECIALTY PHARMA LIMITED has informed the Exchange regarding Allotment of Securities |SUBJECT: Alteration Of Capital and Fund Raising-XBRL
Read Full Analysis →Onesource Specialty Pharma Limited
ONESOURCE SPECIALTY PHARMA LIMITED has informed the Exchange regarding Allotment of Securities |SUBJECT: Alteration Of Capital and Fund Raising-XBRL
Read Full Analysis →Onesource Specialty Pharma Limited
Onesource Specialty Pharma Limited has informed the Exchange regarding a press release dated May 13, 2026, titled "OneSource Announces FY26 Results with Strong Q4 Performance;Reaffirms FY28 Guidance". |SUBJECT: Press Release
Read Full Analysis →Onesource Specialty Pharma Limited
Onesource Specialty Pharma Limited has informed the Exchange about Investor Presentation |SUBJECT: Investor Presentation
Read Full Analysis →Onesource Specialty Pharma Limited
Onesource Specialty Pharma Limited has informed the Exchange Update on Composite Scheme of Arrangement and Amalgamation (Merger by Absorption) amongstSteriscience Specialties Private Limited, Brooks Steriscience Limited, Steriscience Pte. Limited, Strides Pharma Services Private Limited and Onesource Specialty Pharma Limited and their respective shareholders (under section 230 to 232 read with section 234, section 52, section 66 of the Indian Companies Act and under section 210 read with section 212 of The Singapore Companies Act, 1967 and other applicable provisions of the Indian Companies Act, 2013, the Singapore Companies Act, 1967 and the rules framed thereunder ( Proposed Scheme ) |SUBJECT: General Updates
Read Full Analysis →Onesource Specialty Pharma Limited
Onesource Specialty Pharma Limited has informed the Exchange regarding Change in Auditors of the company. |SUBJECT: Change in Auditors
Read Full Analysis →Get instant alerts when ONESOURCE breaks news
Join investors who track Onesource Specialty Pharma Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for ONESOURCE?
ONESOURCE is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Onesource Specialty Pharma Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding ONESOURCE to your custom watchlist.